BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8370105)

  • 21. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
    Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R
    Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Derivatives of 1,4-dihydropyridines as "priviledged structures" and their pharmacological potential].
    Żorniak M; Mitręga K; Krzemiński TF
    Kardiol Pol; 2011; 69 Suppl 3():100-3. PubMed ID: 22125212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Synthesis of 1,4-dihydropyridines with blood pressure and blood-fat lowering effects].
    Zhang S; Zhao D; Mei Q; Feng R
    Yao Xue Xue Bao; 1998 Oct; 33(10):789-92. PubMed ID: 12016935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. II.
    Morita I; Kunimoto K; Tsuda M; Tada S; Kise M; Kimura K
    Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4144-54. PubMed ID: 3435941
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on nilvadipine. I. Synthesis and structure-activity relationships of 1,4-dihydropyridines containing novel substituents at the 2-position.
    Satoh Y; Ichihashi M; Okumura K
    Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3189-201. PubMed ID: 1814611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
    Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
    Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel 1,4-dihydropyridine calcium antagonists. I. Synthesis and hypotensive activity of 4-(substituted pyridyl)-1,4-dihydropyridine derivatives.
    Ashimori A; Ono T; Uchida T; Ohtaki Y; Fukaya C; Watanabe M; Yokoyama K
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2446-58. PubMed ID: 2285975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. I.
    Morita I; Tada S; Kunimoto K; Tsuda M; Kise M; Kimura K
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3898-904. PubMed ID: 3435985
    [No Abstract]   [Full Text] [Related]  

  • 30. Regional vascular effects of MPC-1304, a novel dihydropyridine derivative, in conscious normotensive and spontaneously hypertensive rats.
    Miyoshi K; Kanda A; Nozawa Y; Nakano M; Miyake H
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1328-36. PubMed ID: 8667194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and crystal structure of optically active 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate (NZ-105).
    Sakoda R; Matsumoto H; Seto K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2377-81. PubMed ID: 1446358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T; Kase N; Kita H; Uematsu T
    Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of some novel hydrazide, 1,2-dihydropyridine, chromene derivatives carrying biologically active sulfone moieties with potential anticancer activity.
    Bashandy MS; Al-Said MS; Al-Qasoumi SI; Ghorab MM
    Arzneimittelforschung; 2011; 61(9):521-6. PubMed ID: 22029229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on agents with vasodilator and beta-blocking activities. I.
    Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1609-16. PubMed ID: 7954913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, QSAR and calcium channel antagonist activity of new 1,4-dihydropyridine derivatives containing 1-methyl-4,5-dichloroimidazolyl substituents.
    Hosseini M; Miri R; Amini M; Mirkhani H; Hemmateenejad B; Ghodsi S; Alipour E; Shafiee A
    Arch Pharm (Weinheim); 2007 Oct; 340(10):549-56. PubMed ID: 17849444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of a new class of 1,4-dihydropyridines having a hydroxamic ester group in position 3 with a potential calcium antagonistic activity.
    Inglesi M; Nicola M; Magnetti S
    Farmaco; 1990 Dec; 45(12):1327-40. PubMed ID: 2090142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive effect of a new dihydropyridine calcium entry blocker in conscious hypertensive and normotensive rats.
    Nomura M; Kimura Y; Yoshida M; Satoh S
    Arzneimittelforschung; 1989 Dec; 39(12):1542-5. PubMed ID: 2624602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive dihydropyridines with 1,4,4-trisubstitution.
    Kukla MJ; Breslin HJ; Gill A
    J Med Chem; 1990 Jan; 33(1):223-8. PubMed ID: 2296021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of some novel 1,4-dihydropyridines as potential antitubercular agents.
    Trivedi A; Dodiya D; Dholariya B; Kataria V; Bhuva V; Shah V
    Chem Biol Drug Des; 2011 Nov; 78(5):881-6. PubMed ID: 21895982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and structure-activity relationships of new (5R,8S,10R)-ergoline derivatives with antihypertensive or dopaminergic activity.
    Ohno S; Koumori M; Adachi Y; Mizukoshi K; Nagasaka M; Ichihara K
    Chem Pharm Bull (Tokyo); 1994 Oct; 42(10):2042-8. PubMed ID: 7805128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.